These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3022784)

  • 1. An open study of vitamin D3 treatment in psoriasis vulgaris.
    Morimoto S; Yoshikawa K; Kozuka T; Kitano Y; Imanaka S; Fukuo K; Koh E; Kumahara Y
    Br J Dermatol; 1986 Oct; 115(4):421-9. PubMed ID: 3022784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoriasis and vitamin D3. A review of our experience.
    Morimoto S; Yoshikawa K
    Arch Dermatol; 1989 Feb; 125(2):231-4. PubMed ID: 2536537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of psoriasis vulgaris by oral administration of 1 alpha-hydroxyvitamin D3--open-design study.
    Morimoto S; Yoshikawa K; Kozuka T; Kitano Y; Imanaka S; Fukuo K; Koh E; Onishi T; Kumahara Y
    Calcif Tissue Int; 1986 Sep; 39(3):209-12. PubMed ID: 3093033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolites of vitamin D in human vitamin-D deficiency: effect of vitamin D3 or 1,25-dihydroxycholecalciferol.
    Papapoulos SE; Clemens TL; Fraher LJ; Gleed J; O'Riordan JL
    Lancet; 1980 Sep; 2(8195 pt 1):612-5. PubMed ID: 6107407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical administration of 1,25-dihydroxyvitamin D3 for psoriasis: report of five cases.
    Morimoto S; Onishi T; Imanaka S; Yukawa H; Kozuka T; Kitano Y; Yoshikawa K; Kumahara Y
    Calcif Tissue Int; 1986 Feb; 38(2):119-22. PubMed ID: 3082494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of vitamin D3 derivatives in the treatment of psoriasis vulgaris: a preliminary report.
    el-Azhary RA; Peters MS; Pittelkow MR; Kao PC; Muller SA
    Mayo Clin Proc; 1993 Sep; 68(9):835-41. PubMed ID: 8396699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of effect of 24,25-dihydroxyvitamin D3 in primary hyperparathyroidism.
    Netelenbos JC; Asscheman H; Lips P; Van der Vijgh WJ; Jongen MJ; Van Ginkel F; Hackeng WH
    J Clin Endocrinol Metab; 1986 Jul; 63(1):246-8. PubMed ID: 3486877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis.
    van de Kerkhof PC; Berth-Jones J; Griffiths CE; Harrison PV; Hönigsmann H; Marks R; Roelandts R; Schöpf E; Trompke C
    Br J Dermatol; 2002 Mar; 146(3):414-22. PubMed ID: 11952541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
    Kooh SW; Fraser D; DeLuca HF; Holick MF; Belsey RE; Clark MB; Murray TM
    N Engl J Med; 1975 Oct; 293(17):840-4. PubMed ID: 170516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative therapeutic effects of vitamin D3 and its derivatives on experimental renal osteodystrophy.
    Fukushima M; Niki R; Ohkawa H; Shimizu T; Matsunaga I; Nakano H; Takagaki Y; Nishii Y; Okano K; Suda T
    Endocrinology; 1980 Jul; 107(1):328-33. PubMed ID: 6247140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of psoriasis vulgaris with oral 1 alpha,25-dihydroxyvitamin D3--report of two cases.
    Morimoto S; Yoshikawa K; Kozuka T; Kitano Y; Imanaka S; Fukuo K; Koh E; Hironaka T; Zen A; Nabata T
    J Dermatol; 1987 Feb; 14(1):59-62. PubMed ID: 3301950
    [No Abstract]   [Full Text] [Related]  

  • 12. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.
    Hughes MR; Baylink DJ; Jones PG; Haussler MR
    J Clin Invest; 1976 Jul; 58(1):61-70. PubMed ID: 1084355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK; Lyles KW; Haussler MR; Harrelson JM
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D supplementation for prevention of mortality in adults.
    Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Wetterslev J; Simonetti RG; Bjelakovic M; Gluud C
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD007470. PubMed ID: 24414552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal hypophosphatemic rickets: growth acceleration after long-term treatment with 1,25-dihydroxyvitamin-D3.
    Chan JC; Lovinger RD; Mamunes P
    Pediatrics; 1980 Sep; 66(3):445-54. PubMed ID: 6893489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D3 and calcium to prevent hip fractures in elderly women.
    Chapuy MC; Arlot ME; Duboeuf F; Brun J; Crouzet B; Arnaud S; Delmas PD; Meunier PJ
    N Engl J Med; 1992 Dec; 327(23):1637-42. PubMed ID: 1331788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavior of calciotropic hormones in psoriasis.
    Rico H; Robledo A; Crabranes JA; Lopez-Bran E; Hernandez ER
    Miner Electrolyte Metab; 1991; 17(1):12-5. PubMed ID: 1770911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of 1 alpha-hydroxy-and 1,25-dihydroxyvitamin D3 in the treatment of renal bone disease.
    Kanis JA; Russell RG; Cundy T; Earnshaw M; Woods CG; Smith R; Heynen G
    Contrib Nephrol; 1980; 18():12-28. PubMed ID: 7353370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of thyroid function on the serum concentration of 1,25-dihydroxyvitamin D3.
    Bouillon R; Muls E; De Moor P
    J Clin Endocrinol Metab; 1980 Oct; 51(4):793-7. PubMed ID: 6893457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vitamin D3 metabolites in ovariectomized rats.
    Orimo H; Tsutsumi C; Hosoya N; Maeda Y; Yamato H; Katoh T
    J Int Med Res; 1989; 17(3):243-8. PubMed ID: 2788587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.